Portside Wealth Group LLC Invests $249,000 in Stevanato Group S.p.A. $STVN

Portside Wealth Group LLC bought a new position in shares of Stevanato Group S.p.A. (NYSE:STVNFree Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 10,179 shares of the company’s stock, valued at approximately $249,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Twin Tree Management LP acquired a new position in Stevanato Group in the first quarter valued at approximately $29,000. SVB Wealth LLC purchased a new stake in shares of Stevanato Group during the 1st quarter worth approximately $46,000. Van Berkom & Associates Inc. boosted its holdings in shares of Stevanato Group by 33.3% in the 1st quarter. Van Berkom & Associates Inc. now owns 2,400 shares of the company’s stock valued at $49,000 after buying an additional 600 shares in the last quarter. First Horizon Advisors Inc. boosted its holdings in shares of Stevanato Group by 14.9% in the 2nd quarter. First Horizon Advisors Inc. now owns 3,833 shares of the company’s stock valued at $94,000 after buying an additional 497 shares in the last quarter. Finally, Hilltop National Bank purchased a new position in shares of Stevanato Group in the 2nd quarter valued at $158,000.

Stevanato Group Price Performance

Shares of NYSE:STVN opened at €21.19 on Friday. Stevanato Group S.p.A. has a one year low of €17.81 and a one year high of €28.00. The stock has a market capitalization of $6.42 billion, a price-to-earnings ratio of 37.17, a PEG ratio of 2.09 and a beta of 0.56. The company has a 50-day simple moving average of €24.98 and a 200-day simple moving average of €24.27. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.30 and a current ratio of 1.89.

Analyst Ratings Changes

A number of brokerages recently weighed in on STVN. Weiss Ratings reissued a “hold (c+)” rating on shares of Stevanato Group in a research report on Monday. Morgan Stanley upped their target price on Stevanato Group from $24.00 to $26.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 11th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Stevanato Group has a consensus rating of “Moderate Buy”.

View Our Latest Report on STVN

About Stevanato Group

(Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Featured Articles

Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVNFree Report).

Institutional Ownership by Quarter for Stevanato Group (NYSE:STVN)

Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.